Media Kit

DAVID PICKAR, MD

Author of Edges of the Mind: Treating Schizophrenia as Psychiatry Evolves

David Pickar, MD, is an internationally recognized psychiatrist, researcher, and educator whose work helped shape the modern understanding and treatment of schizophrenia. Through more than four decades of clinical practice, research, and leadership, he has witnessed—and contributed to the transformation of psychiatry into a neuroscience-based discipline.

Author at a Glance

40+
YEARS
Psychiatry and
neuroscience leadership
400+
SCIENTIFIC
PUBLICATIONS
20+
YEARS
Research leadership
at NIMH
YALE-TRAINED
Psychiatrist and
clinician-scientist
JOHNS HOPKINS
FACULTY
Adjunct Professor of
Psychiatry
DISTINGUISHED
LIFE FELLOW
American Psychiatric
Association

Official Author Biographies

SHORT BIO

David Pickar, M.D., is a psychiatrist, neuroscientist, and longtime advocate for people living with serious mental illness. A former research leader at the National Institute of Mental Health, where he served as Chief of the Experimental Therapeutics Branch, Dr. Pickar is an Adjunct Professor of Psychiatry at the Johns Hopkins University School of Medicine and the Uniformed Services University of the Health Sciences. He has authored or co-authored more than 400 peer-reviewed scientific publications and continues to practice psychiatry in Chevy Chase, Maryland.

MEDIUM BIO

David Pickar, M.D., is a psychiatrist, neuroscientist, researcher, and longtime advocate for people living with serious mental illness. Over a career spanning nearly five decades, he has witnessed—and helped shape—the transformation of psychiatry from a discipline dominated by psychoanalytic theory to one increasingly grounded in neuroscience, psychopharmacology, and modern medicine.

After receiving his medical degree and completing his psychiatry residency at Yale University School of Medicine, Dr. Pickar joined the Intramural Research Program of the National Institute of Mental Health. He spent more than 20 years at NIMH as a clinician-scientist and research leader, ultimately serving as Chief of the Experimental Therapeutics Branch. His work focused on schizophrenia, psychosis, and the development of more effective psychiatric treatments, including pharmacologic strategies that remain in clinical development.

Dr. Pickar has authored or co-authored more than 400 scientific publications. He is a Distinguished Life Fellow of the American Psychiatric Association, a Fellow Emeritus of the American College of Neuropsychopharmacology, and an Adjunct Professor of Psychiatry at the Johns Hopkins University School of Medicine and the Uniformed Services University of the Health Sciences.

He continues to practice psychiatry in Chevy Chase, Maryland, with an emphasis on caring for people with serious mental illness. Throughout his career, he has remained committed to advancing both the science of psychiatry and the humane treatment of individuals and families affected by severe psychiatric disorders.

FULL BIO

David Pickar, M.D., is a psychiatrist, neuroscientist, researcher, biotechnology entrepreneur, and longtime advocate for people living with serious mental illness. Over a career spanning nearly five decades, his work has encompassed schizophrenia and psychosis research, psychiatric drug development, clinical practice, public service, medical education, and science communication.

Dr. Pickar is an Adjunct Professor of Psychiatry at the Johns Hopkins University School of Medicine and the Uniformed Services University of the Health Sciences. He is a Distinguished Life Fellow of the American Psychiatric Association and a Fellow Emeritus of the American College of Neuropsychopharmacology. From 2014 to 2018, he served on the U.S. Food and Drug Administration’s Psychopharmacologic Drugs Advisory Committee, contributing his expertise to the evaluation of psychiatric medications and emerging treatments.

For more than 20 years, Dr. Pickar served in the Intramural Research Program of the National Institute of Mental Health, where he became Chief of the Experimental Therapeutics Branch. His research focused on schizophrenia, psychosis, neuropsychopharmacology, and the development of more effective psychiatric treatments. His work identifying the potential therapeutic effects of alpha-2 antagonist adjunctive treatment for schizophrenia helped establish the foundation for a treatment approach that is now in clinical development.

ABOUT THE BOOK

Edges of the Mind

TREATING SCHIZOPHRENIA AS PSYCHIATRY EVOLVES

A powerful memoir and front-row account of the scientific breakthroughs, clinical trials, and human stories that reshaped our understanding of schizophrenia and transformed modern psychiatry.

PUBLICATION DATE

Fall 2026

ISBN

To be announced

PUBLISHER

Suburban Media Group

FORMAT

Hardcover, Paperback

PAGES

To be announced

GENRE

Memoir / Science / Medicine

Interview Topics

  • Schizophrenia and Serious Mental Illness

  • The Evolution of Psychiatry

  • Breakthroughs in Neuroscience

  • Mental Health Policy

  • Hope and Recovery in Serious Mental Illness

  • The Future of Psychiatric Treatment

  • Lessons From Four Decades of Research

  • Behind the Stories in Edges of the Mind

Suggested Interview Questions

  • Why did you write Edges of the Mind?

  • What has changed most dramatically in psychiatry during your career?

  • What misconceptions about schizophrenia concern you most?

  • What gives you hope for the future?

  • How has neuroscience changed mental health treatment?

  • What do you want readers to take away from the

Speaking & Appearances

Dr. Pickar is available for:

  • Conferences

  • Universities

  • Medical schools

  • Mental health organizations

  • Podcasts

  • Television interviews

  • Keynote presentations

  • Book events

Book Announcement Press Release

Edges of the Mind: Treating Schizophrenia as Psychiatry Evolves by David Pickar, MD

Follow Dr. Pickar

Follow Dr. Pickar

Stay connected for insights, updates, and behind-the-scenes reflections